A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.

Clinical trial NCT00545532 · COMPLETED

Trial details

NCT number: NCT00545532
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2008-02-04
Primary completion: 2017-05-02
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.